Drug shortages or anticipated issues with HIV drugs haven’t been recognized.
The US Meals and Drug Administration (FDA) is carefully monitoring the drug provide chain because the COVID-19 pandemic has the potential to disrupt the provision of medical and pharmaceutical merchandise in america.
The Nationwide Alliance of State and Territorial AIDS Administrators (NASTAD) has additionally remained in touch with the foremost producers of HIV drugs as many of those merchandise depend on substances produced in different international locations.
As of July 7, 2020, there have been no stories of producing considerations or provide shortages of ART or PrEP.
Study extra about the FDA’s response to COVID-19exterior icon.